Welcome to the NICE Conference Call discussing Fourth Quarter 2024 Results, and thank you all for holding. All participants are at present in a listen-only mode. Following management’s formal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Helen Knight, director of medicines evaluation at NICE This first-of-its-kind treatment works by reprogramming a patient's own immune cells to fight their cancer. Clinical trials have shown the ...

Helen Knight, director of medicines evaluation at NICE Current treatments often do not control seizures caused by LGS. The patient carer experts who gave evidence to the committee noted that the ...

by unlocking targets that have been inaccessible to traditional small molecule discovery approaches,” Abraham Heifets, co-founder and CEO of Atomwise, said in a statement. “We are pleased to ...

At one memorable panel at Fierce JPM Week, Vivodyne CEO Abraham Heifets described how tech and pharma are almost opposites in how they do business: tech companies secure a first-mover advantage ...

After hours: March 14 at 7:48:04 PM EDT Loading Chart for NICE ...

Kate has a BSc in Microbiology from the University of Manchester and a PhD in virology from the University of Edinburgh. Following this, she completed a post-doc at the Jenner Institute, University of ...